Michael J. Roberts, VP, Business Development at Chelsea Therapeutics International, Ltd. (CHTP), bought 2,000 shares at $3.10 ($6K) on 2010-08-11, disclosed to the SEC on 2010-08-12.
Open-market purchase of $6k CHTP by VP, Business Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.